{"id":5249,"date":"2011-10-17T09:00:00","date_gmt":"2011-10-17T09:00:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/"},"modified":"2024-09-23T11:22:47","modified_gmt":"2024-09-23T11:22:47","slug":"de-stand-van-zaken-rond-de-kunstmatige-alvleesklier","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/","title":{"rendered":"De stand van zaken rond de kunstmatige alvleesklier"},"content":{"rendered":"<p>DiabetesCare.net publiceert het eerste van twee interviews met Breakthrough T1D\u2019s PhD Aaron Kowalski. Hij stuurt het Artificial Pancreas Research Project aan: een erg belangrijk proces voor Breakthrough T1D.<\/p>\n<p>Nieuwsgierig wat de stand van zaken is, als het aankomt op de kunstmatige alvleesklier? Aaron Kowalski deelt de actuele situatie over het cre\u00ebren van een kunstmatige alvleesklier \u00e9n hij vertelt over de problemen in Amerika spelen als het aankomt op goedkeuring van de Amerikaanse Food and Drug Association (FDA).<\/p>\n<p><a href=\"http:\/\/www.diabetescare.net\/up-close\/the-artificial-pancreas-where-are-we-now-part-1\" target=\"_blank\" rel=\"noreferrer noopener\">Het volledige (Engelstalige) eerste interview vind je hier<\/a>.<a href=\"http:\/\/www.diabetescare.net\/content_upclose_detail.asp?id=445774\"><br \/><\/a><\/p>","protected":false,"raw":""},"excerpt":{"rendered":"<p>DiabetesCare.net publiceert het eerste van twee interviews met Breakthrough T1D\u2019s PhD Aaron Kowalski. Hij stuurt het Artificial Pancreas Research Project aan: een erg belangrijk proces voor Breakthrough T1D. Nieuwsgierig wat de stand van zaken is, als het aankomt op de kunstmatige alvleesklier? Aaron Kowalski deelt de actuele situatie over het cre\u00ebren van een kunstmatige alvleesklier [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184,187,188,190],"tags":[],"class_list":["post-5249","post","type-post","status-publish","format-standard","hentry","category-archief","category-behandelen","category-genezen","category-kunstmatige-alvleesklier"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>De stand van zaken rond de kunstmatige alvleesklier - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"De stand van zaken rond de kunstmatige alvleesklier - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"DiabetesCare.net publiceert het eerste van twee interviews met Breakthrough T1D\u2019s PhD Aaron Kowalski. Hij stuurt het Artificial Pancreas Research Project aan: een erg belangrijk proces voor Breakthrough T1D. Nieuwsgierig wat de stand van zaken is, als het aankomt op de kunstmatige alvleesklier? Aaron Kowalski deelt de actuele situatie over het cre\u00ebren van een kunstmatige alvleesklier [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2011-10-17T09:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T11:22:47+00:00\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"De stand van zaken rond de kunstmatige alvleesklier\",\"datePublished\":\"2011-10-17T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/\"},\"wordCount\":98,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"articleSection\":[\"Archief\",\"Behandelen\",\"Genezen\",\"Kunstmatige alvleesklier\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/\",\"name\":\"De stand van zaken rond de kunstmatige alvleesklier - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"datePublished\":\"2011-10-17T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"De stand van zaken rond de kunstmatige alvleesklier\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"De stand van zaken rond de kunstmatige alvleesklier - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/","og_locale":"nl_NL","og_type":"article","og_title":"De stand van zaken rond de kunstmatige alvleesklier - Breakthrough T1D","og_description":"DiabetesCare.net publiceert het eerste van twee interviews met Breakthrough T1D\u2019s PhD Aaron Kowalski. Hij stuurt het Artificial Pancreas Research Project aan: een erg belangrijk proces voor Breakthrough T1D. Nieuwsgierig wat de stand van zaken is, als het aankomt op de kunstmatige alvleesklier? Aaron Kowalski deelt de actuele situatie over het cre\u00ebren van een kunstmatige alvleesklier [&hellip;]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/","og_site_name":"Breakthrough T1D","article_published_time":"2011-10-17T09:00:00+00:00","article_modified_time":"2024-09-23T11:22:47+00:00","author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"De stand van zaken rond de kunstmatige alvleesklier","datePublished":"2011-10-17T09:00:00+00:00","dateModified":"2024-09-23T11:22:47+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/"},"wordCount":98,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"articleSection":["Archief","Behandelen","Genezen","Kunstmatige alvleesklier"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/","name":"De stand van zaken rond de kunstmatige alvleesklier - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"datePublished":"2011-10-17T09:00:00+00:00","dateModified":"2024-09-23T11:22:47+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/de-stand-van-zaken-rond-de-kunstmatige-alvleesklier\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"De stand van zaken rond de kunstmatige alvleesklier"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5249"}],"version-history":[{"count":1,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5249\/revisions"}],"predecessor-version":[{"id":7358,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5249\/revisions\/7358"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5249"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5249"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}